Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBOAT4 | Q96T53 | 19/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3133514 | 0.92 | MBOAT4 (0.43) | MBOAT4GAAHTTSMN1; SMN2 | |
| SCHEMBL303749 | 0.90 | GAA (0.45) | MBOAT4GAAHTTSMN1; SMN2 | |
| SCHEMBL3130141 | 0.90 | GAA (0.45) | MBOAT4GAAHTTSMN1; SMN2 | |
| SCHEMBL3133063 | 0.90 | GAA (0.45) | MBOAT4GAAHTTSMN1; SMN2 | |
| SCHEMBL5402153 | 0.90 | GAA (0.45) | MBOAT4GAAHTTSMN1; SMN2 | |
| SCHEMBL10623174 | 0.88 | MBOAT4 (0.48) | MBOAT4 | |
| SCHEMBL3871870 | 0.85 | GAA (0.42) | MBOAT4GAAHTTSMN1; SMN2 | |
| SCHEMBL3876315 | 0.85 | GAA (0.42) | MBOAT4GAAHTTSMN1; SMN2 | |
| SCHEMBL4921904 | 0.85 | GAA (0.45) | MBOAT4GAAHTTSMN1; SMN2 | |
| SCHEMBL3132086 | 0.83 | GAA (0.45) | MBOAT4GAAHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080262000-A1 | 5-Alkoxyalkyl-6-alkyl-7-Aminoazolopyrimidines, Process for Their Preparation, Their Use for Controlling Harmful Fungi, and Compositions Comprising Them | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-23 | — | — | US | disclosed |
| US-20080262000-A1 | 5-Alkoxyalkyl-6-alkyl-7-Aminoazolopyrimidines, Process for Their Preparation, Their Use for Controlling Harmful Fungi, and Compositions Comprising Them | BASF AKTIENGESELLSCHAFT (DE) | 2008-10-23 | — | — | US | disclosed |
| EP-1853608-B1 | 5-ALKOXYALKYL-6-ALKYL-7-AMINO-AZOLOPYRIMIDINES, METHOD FOR THEIR PRODUCTION, THEIR USE FOR CONTROLLING PATHOGENIC FUNGI AND AGENTS CONTAINING SAID SUBSTANCES | BASF SE (DE) | 2008-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262000-A1 | 5-Alkoxyalkyl-6-alkyl-7-Aminoazolopyrimidines, Process for Their Preparation, Their Use for Controlling Harmful Fungi, and Compositions Comprising Them | NT5C3B, RNGTT, CBR3 | MBOAT4 4594/4885GAA 2800/4885HTT 2641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.